Quick Answer
CervoMed Inc. reported Research And Development Expense of $21.82 million for the year ending 2025.
- CervoMed Inc. showed an increase of +16.1% in Research And Development Expense from 2024 to 2025.
- This data is from CervoMed Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $169.3 thousand | Q2 2014: $266.9 thousand | Q3 2014: $1.27 million | Q1 2015: $731.9 thousand | Q2 2015: $948.8 thousand | Q3 2015: $922.2 thousand | Q1 2016: $2.35 million | Q2 2016: $1.44 million | Q3 2016: $1.94 million | Q1 2017: $1.01 million | Q2 2017: $1.18 million | Q3 2017: $1.76 million | Q1 2018: $1.83 million | Q2 2018: $1.39 million | Q3 2018: $1.17 million | Q1 2019: $1.70 million | Q2 2019: $1.52 million | Q3 2019: $1.74 million | Q1 2020: $1.53 million | Q2 2020: $2.17 million | Q3 2020: $3.14 million | Q1 2021: $2.92 million | Q2 2021: $1.97 million | Q3 2021: $2.11 million | Q1 2022: $2.43 million | Q2 2022: $2.11 million | Q3 2022: $330.5 thousand | Q1 2023: $1.83 million | Q2 2023: $1.96 million | Q3 2023: $1.79 million | Q1 2024: $2.81 million | Q2 2024: $3.77 million | Q3 2024: $5.13 million | Q1 2025: $4.84 million | Q2 2025: $5.11 million | Q3 2025: $6.04 million.
- Over the full 13 years of available data (2013 to 2025), CervoMed Inc.'s Research And Development Expense has grown by 6,262.2%.
- Historical annual values: Fiscal year 2025: $21.82 million | Fiscal year 2024: $18.80 million | Fiscal year 2023: $8.44 million | Fiscal year 2022: $1.34 million | Fiscal year 2021: $8.50 million | Fiscal year 2020: $9.43 million | Fiscal year 2019: $6.62 million | Fiscal year 2018: $5.75 million | Fiscal year 2017: $5.09 million | Fiscal year 2016: $7.25 million | Fiscal year 2015: $3.88 million | Fiscal year 2014: $2.86 million | Fiscal year 2013: $342.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: